Skip to content

Body Composition Study in Critically Ill Patients-Extended to COVID-19

Body Composition Study in Critically Ill Patients-Extended to COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04849624
Acronym
COVID-MUSCLE
Enrollment
59
Registered
2021-04-19
Start date
2021-03-05
Completion date
2024-11-01
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Critical Illness, Muscle Atrophy, Muscle Strength

Brief summary

Muscle loss (ultrasound quadricep muscle) and muscle strength (handgrip and knee extension strength) will be compared between COVID-19 and non COVID-19 critically ill patients.

Detailed description

Given the heightened inflammatory status among COVID-19 critically ill patients, we hypothesized that the rate of skeletal muscle loss is accelerated in this population, and this loss is even more pronounce than the general critically ill patients. We further hypothesized that the increased muscle loss will lead to worse functional outcome (lower muscle strength) in COVID-19 critically ill patients compared with age- and sex-matched non-COVID-19 critically ill patients, as it has been shown that quadriceps thickness is strongly correlated with functional status at ICU discharge. Furthermore, a recent systematic review and meta-analysis in survivors of coronavirus (severe acute respiratory syndrome, SARS or Middle-east respiratory syndrome, MERS, or COVID-19) also demonstrated reduced exercise capacity and quality of life at 6 months after hospitalization or ICU admission

Interventions

OTHERNo Intervention

This is an observational study and involved no intervention

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years old * Admitted into the ICU due to COVID-19

Exclusion criteria

* Likely to transfer out from the ICU in 24 hours from screening * Likely to die in the next 7 days * Bedbound prior to hospital admission or bedbound in the hospital for \>10 days

Design outcomes

Primary

MeasureTime frameDescription
Rectus Femoris ThicknessChange in Rectus Femoris Thickness at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)Change in Rectus Femoris Thickness
Rectus Femoris Cross-sectional AreaChange in Rectus Femoris Cross-sectional Area at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)Change in Rectus Femoris Cross-sectional Area

Secondary

MeasureTime frameDescription
Forearm Muscle ThicknessChange in Forearm Muscle Thickness at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)Change in Forearm Muscle Thickness
Handgrip StrengthBefore Hospital DischargeBIlateral Handgrip Strength
Knee Extension StrengthBefore Hospital DischargeBIlateral Knee Extension Strength

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026